Review



inhibitors recombinant murine fgf8  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems inhibitors recombinant murine fgf8
    Inhibitors Recombinant Murine Fgf8, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 98 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/inhibitors recombinant murine fgf8/product/R&D Systems
    Average 93 stars, based on 98 article reviews
    inhibitors recombinant murine fgf8 - by Bioz Stars, 2026-03
    93/100 stars

    Images



    Similar Products

    93
    R&D Systems inhibitors recombinant murine fgf8
    Inhibitors Recombinant Murine Fgf8, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/inhibitors recombinant murine fgf8/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    inhibitors recombinant murine fgf8 - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    90
    FUJIFILM human recombinant fgf8
    Human Recombinant Fgf8, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human recombinant fgf8/product/FUJIFILM
    Average 90 stars, based on 1 article reviews
    human recombinant fgf8 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    STEMCELL Technologies Inc recombinant fgf8-a
    Recombinant Fgf8 A, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant fgf8-a/product/STEMCELL Technologies Inc
    Average 90 stars, based on 1 article reviews
    recombinant fgf8-a - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    FUJIFILM recombinant human fgf8
    Recombinant Human Fgf8, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human fgf8/product/FUJIFILM
    Average 90 stars, based on 1 article reviews
    recombinant human fgf8 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    93
    R&D Systems fgf8
    Fgf8, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fgf8/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    fgf8 - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    R&D Systems fgf8 recombinant mouse protein
    Integration of FGF signaling and elongation speed response (A) Representative confocal images of control embryos and embryos treated with the FGF inhibitor PD173074 for 30 min. Hoechst signal is shown on the left, the pMAPK signal is shown in the middle, Hoechst signal with PSM shape drawn for intensity analysis (using Fiji) is shown on the right. Regularly appearing, blurry dark horizontal lines are artifacts of the stitching of tiled confocal image edges. Scale bar: 100μm. (B) Average fluorescence intensity (normalized to the average intensity of the most posterior point +100μm on either side, bars indicate the mean, same in panel C) of pMAPK for controls (DMSO) and treated with PD173074 for 30 min and 1h. n = 15 (8 embryos) for DMSO Controls, n = 8 (4 embryos) for 30 min PD173074, n = 7 (4 embryos) for 1h PD173074 (∗∗ p = 0.0089, 30 min: n.s. p = 0.058, 1h: n.s. p = 0.95, paired t-test applied to samples for which there are datapoints at the two ends as not all pPSM images reach 600μm, same in panel C, n = 6 for 30 min PD173074). (C) Average fluorescence intensity of pMAPK for controls, after pulling and after compression. n = 20 (10 embryos) for controls, n = 9 for compressed (5 embryos), n = 10 for pulled (5 embryos) (∗∗∗p = 3e-4, ∗∗ p = 0.0017, n.s. p = 0.11, paired t-tests, n = 7 for compressed). (D) Elongation speed dynamics following pulling + <t>FGF8</t> addition. n = 5 for control and pulled, n = 4 for +FGF8 and n = 6 for pulled + FGF8 (0-1h: ∗∗p = 3e-3, n.s. p = 0.913; 1-2h: ∗p = 7e-3, n.s. p = 0.431; 2 tailed t-tests). Standard boxplots with quartiles, SD error bars are used. (E) Average elongation speed over 4 h after compression + FGF inhibition. n = 12 for control (DMSO), n = 10 for FGF inhibitor (PD173064), n = 6 for compressed DMSO and n = 7 for PD173074 (∗ p = 0.011, ∗∗p = 4e-3, 2 tailed t-tests). Standard boxplots with quartiles, SD error bars are used.
    Fgf8 Recombinant Mouse Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fgf8 recombinant mouse protein/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    fgf8 recombinant mouse protein - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    Image Search Results


    Integration of FGF signaling and elongation speed response (A) Representative confocal images of control embryos and embryos treated with the FGF inhibitor PD173074 for 30 min. Hoechst signal is shown on the left, the pMAPK signal is shown in the middle, Hoechst signal with PSM shape drawn for intensity analysis (using Fiji) is shown on the right. Regularly appearing, blurry dark horizontal lines are artifacts of the stitching of tiled confocal image edges. Scale bar: 100μm. (B) Average fluorescence intensity (normalized to the average intensity of the most posterior point +100μm on either side, bars indicate the mean, same in panel C) of pMAPK for controls (DMSO) and treated with PD173074 for 30 min and 1h. n = 15 (8 embryos) for DMSO Controls, n = 8 (4 embryos) for 30 min PD173074, n = 7 (4 embryos) for 1h PD173074 (∗∗ p = 0.0089, 30 min: n.s. p = 0.058, 1h: n.s. p = 0.95, paired t-test applied to samples for which there are datapoints at the two ends as not all pPSM images reach 600μm, same in panel C, n = 6 for 30 min PD173074). (C) Average fluorescence intensity of pMAPK for controls, after pulling and after compression. n = 20 (10 embryos) for controls, n = 9 for compressed (5 embryos), n = 10 for pulled (5 embryos) (∗∗∗p = 3e-4, ∗∗ p = 0.0017, n.s. p = 0.11, paired t-tests, n = 7 for compressed). (D) Elongation speed dynamics following pulling + FGF8 addition. n = 5 for control and pulled, n = 4 for +FGF8 and n = 6 for pulled + FGF8 (0-1h: ∗∗p = 3e-3, n.s. p = 0.913; 1-2h: ∗p = 7e-3, n.s. p = 0.431; 2 tailed t-tests). Standard boxplots with quartiles, SD error bars are used. (E) Average elongation speed over 4 h after compression + FGF inhibition. n = 12 for control (DMSO), n = 10 for FGF inhibitor (PD173064), n = 6 for compressed DMSO and n = 7 for PD173074 (∗ p = 0.011, ∗∗p = 4e-3, 2 tailed t-tests). Standard boxplots with quartiles, SD error bars are used.

    Journal: iScience

    Article Title: Cell density couples tissue mechanics to control the elongation speed of the body axis

    doi: 10.1016/j.isci.2024.110968

    Figure Lengend Snippet: Integration of FGF signaling and elongation speed response (A) Representative confocal images of control embryos and embryos treated with the FGF inhibitor PD173074 for 30 min. Hoechst signal is shown on the left, the pMAPK signal is shown in the middle, Hoechst signal with PSM shape drawn for intensity analysis (using Fiji) is shown on the right. Regularly appearing, blurry dark horizontal lines are artifacts of the stitching of tiled confocal image edges. Scale bar: 100μm. (B) Average fluorescence intensity (normalized to the average intensity of the most posterior point +100μm on either side, bars indicate the mean, same in panel C) of pMAPK for controls (DMSO) and treated with PD173074 for 30 min and 1h. n = 15 (8 embryos) for DMSO Controls, n = 8 (4 embryos) for 30 min PD173074, n = 7 (4 embryos) for 1h PD173074 (∗∗ p = 0.0089, 30 min: n.s. p = 0.058, 1h: n.s. p = 0.95, paired t-test applied to samples for which there are datapoints at the two ends as not all pPSM images reach 600μm, same in panel C, n = 6 for 30 min PD173074). (C) Average fluorescence intensity of pMAPK for controls, after pulling and after compression. n = 20 (10 embryos) for controls, n = 9 for compressed (5 embryos), n = 10 for pulled (5 embryos) (∗∗∗p = 3e-4, ∗∗ p = 0.0017, n.s. p = 0.11, paired t-tests, n = 7 for compressed). (D) Elongation speed dynamics following pulling + FGF8 addition. n = 5 for control and pulled, n = 4 for +FGF8 and n = 6 for pulled + FGF8 (0-1h: ∗∗p = 3e-3, n.s. p = 0.913; 1-2h: ∗p = 7e-3, n.s. p = 0.431; 2 tailed t-tests). Standard boxplots with quartiles, SD error bars are used. (E) Average elongation speed over 4 h after compression + FGF inhibition. n = 12 for control (DMSO), n = 10 for FGF inhibitor (PD173064), n = 6 for compressed DMSO and n = 7 for PD173074 (∗ p = 0.011, ∗∗p = 4e-3, 2 tailed t-tests). Standard boxplots with quartiles, SD error bars are used.

    Article Snippet: FGF8 recombinant mouse protein , R&D systems , 424-FC-025/CF.

    Techniques: Control, Fluorescence, Inhibition

    Journal: iScience

    Article Title: Cell density couples tissue mechanics to control the elongation speed of the body axis

    doi: 10.1016/j.isci.2024.110968

    Figure Lengend Snippet:

    Article Snippet: FGF8 recombinant mouse protein , R&D systems , 424-FC-025/CF.

    Techniques: Recombinant, Software